Education
About Us
Working with TipRanks
Follow Us
EQL Pharma AB (DE:7JK)
FRANKFURT:7JK
7JK Stock Chart & Stats
€4.44
-€0.30(-4.10%)
At close: 4:00 PM EST
€4.44
-€0.30(-4.10%)
Day’s Range― - ―
52-Week Range€4.29 - €8.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€133.29M
Enterprise Value€2.32B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)48.9
Beta0.37
Next Earnings
Feb 17, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding29,529,610
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EQL Pharma AB News
7JK FAQ
What was EQL Pharma AB’s price range in the past 12 months?
EQL Pharma AB lowest stock price was €4.29 and its highest was €8.80 in the past 12 months.
What is EQL Pharma AB’s market cap?
EQL Pharma AB’s market cap is €133.29M.
When is EQL Pharma AB’s upcoming earnings report date?
EQL Pharma AB’s upcoming earnings report date is Feb 17, 2026 which is in 61 days.
How were EQL Pharma AB’s earnings last quarter?
EQL Pharma AB released its earnings results on Nov 07, 2025. The company reported -€0.01 earnings per share for the quarter, missing the consensus estimate of -€0.005 by -€0.005.
Is EQL Pharma AB overvalued?
According to Wall Street analysts EQL Pharma AB’s price is currently Overvalued.
Does EQL Pharma AB pay dividends?
EQL Pharma AB does not currently pay dividends.
What is EQL Pharma AB’s EPS estimate?
EQL Pharma AB’s EPS estimate is 0.01.
How many shares outstanding does EQL Pharma AB have?
EQL Pharma AB has 29,529,610 shares outstanding.
What happened to EQL Pharma AB’s price movement after its last earnings report?
EQL Pharma AB reported an EPS of -€0.01 in its last earnings report, missing expectations of -€0.005. Following the earnings report the stock price went down -3.239%.
Which hedge fund is a major shareholder of EQL Pharma AB?
Currently, no hedge funds are holding shares in DE:7JK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
EQL Pharma AB
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
BICO Group AB Class B
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―